Citation Impact
Citing Papers
Physical Activity and Public Health
2007 Standout
Localization and activity of the SNARE Ykt6 determined by its regulatory domain and palmitoylation
2004 StandoutNobel
TOR Signaling in Growth and Metabolism
2006 Standout
Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability
2002 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Thematic review series: Lipid Posttranslational Modifications. Farnesyl transferase inhibitors
2005
How Many Steps/Day Are Enough?
2004 Standout
Differential Membrane Localization of ERas and Rheb, Two Ras-related Proteins Involved in the Phosphatidylinositol 3-Kinase/mTOR Pathway
2005 StandoutNobel
Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions
2024 StandoutNobel
Analysis of the genome to personalize therapy for melanoma
2010
Apoptosis in cancer
2000 Standout
Suicide and Suicidal Behavior
2008 Standout
Alcohol screening and brief intervention in primary care: Absence of evidence for efficacy in people with dependence or very heavy drinking
2010
Criterion-related validity of the Borg ratings of perceived exertion scale in healthy individuals: a meta-analysis
2002
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Physical Activity and Public Health
2007 Standout
UCF116, New Inhibitors of Farnesyltransferase Produced by Streptomyces.
2000
Neuropsychopharmacology and the genetics of schizophrenia
2004
Farnesyltransferase inhibitors: targeting the molecular basis of cancer
1999
Farnesyltransferase inhibitors: promises and realities
2002
Exercise Standards for Testing and Training
2013 Standout
Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots
2014
Effects of an Intervention Brochure on Emergency Department Patients' Safe Alcohol Use and Knowledge
2008
Enhanced FTase activity achieved via piperazine interaction with catalytic zinc
2005
Monitoring Training Load to Understand Fatigue in Athletes
2014 Standout
Screening for type 2 diabetes with random finger‐prick glucose and bedside HbA1c in an Australian emergency department
2010
Farnesyl transferase inhibitors as anticancer agents
2002
Oreganic Acid, a Potent Inhibitor of Ras Farnesyl-Protein Transferase
1997
Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?
1997
Mitochondria: More Than Just a Powerhouse
2006 Standout
Medical use, medical misuse, and nonmedical use of prescription opioids: Results from a longitudinal study
2013
High-Intensity Interval Training, Solutions to the Programming Puzzle
2013
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
The Farnesyl Transferase Inhibitor (FTI) SCH66336 (lonafarnib) Inhibits Rheb Farnesylation and mTOR Signaling
2005
Platelet-derived Growth Factor Receptor Tyrosine Phosphorylation Requires Protein Geranylgeranylation but not Farnesylation
1996
Peptidomimetic design
1998
Muscular exercise can cause highly pathological liver function tests in healthy men
2007
Barriers and facilitators to implementing screening and brief intervention for alcohol misuse: a systematic review of qualitative evidence
2010
Chemotherapy and the war on cancer
2005 Standout
Protein Prenyltransferases
1996
The microenvironment of the tumour–host interface
2001 StandoutNature
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Trends in Opioid Analgesic Abuse and Mortality in the United States
2015 Standout
Effectiveness of screening and brief alcohol intervention in primary care (SIPS trial): pragmatic cluster randomised controlled trial
2013
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Making sense of implementation theories, models and frameworks
2015 Standout
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
2013 Standout
Systematic review of alcohol screening tools for use in the emergency department
2010
Fundamentals of Resistance Training: Progression and Exercise Prescription
2004 Standout
Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: Implications in prevention of apoptosis
1999
The Neuroendocrinology of Stress: A Never Ending Story
2008 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Crystallographic Analysis of CaaX Prenyltransferases Complexed with Substrates Defines Rules of Protein Substrate Selectivity
2004
Farnesyltransferase Inhibitors: Preclinical Development
1999
Search for Protein Farnesyltransferase Inhibitors of Microbial Origin: Our Strategy and Results as well as the Results Obtained by Other Groups
2007 StandoutNobel
Therapeutic intervention and signaling
1998
High-Intensity Interval Training, Solutions to the Programming Puzzle
2013
Let Them Roam Free?
2009
Small GTP-Binding Proteins
2001 Standout
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
2000 StandoutNobel
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Influence of Family Life on the Course of Schizophrenic Disorders: A Replication
1972 Standout
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Synthesis of Quinoxalines Under Focussed Microwave Irradiation
1995
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Halogen Bonding Based Recognition Processes: A World Parallel to Hydrogen Bonding
2005 Standout
Some applications of biometry in the collection and evaluation of medical data
1955
Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer
2003
A Field Guide to Foldamers
2001 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Physiological adaptations to interval training and the role of exercise intensity
2016 Standout
Epidemiology ofDSM-5Alcohol Use Disorder
2015 Standout
Metalated Heterocycles and Their Applications in Synthetic Organic Chemistry
2004
Physical Activity and Public Health in Older Adults
2007 Standout
Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies
2018
Functional Oligothiophenes: Molecular Design for Multidimensional Nanoarchitectures and Their Applications
2009 Standout
ACSM Position Stand: The Recommended Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory and Muscular Fitness, and Flexibility in Healthy Adults
1998 Standout
Microwave assisted organic synthesis—a review
2001 Standout
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
1959 Standout
The Halogen Bond
2016 Standout
Exercise and Hypertension
2004 Standout
The Impact of Screening, Brief Intervention, and Referral for Treatment on Emergency Department Patients' Alcohol Use
2007
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Complexes of Acridine and 9‐Chloroacridine with I 2 : Formation of Unusual I 6 Chains through Charge‐Transfer Interactions Involving Amphoteric I 2
2000
THE EFFECT OF IPRONIAZID AND IMIPRAMINE ON THE BLOOD PLATELET 5‐HYDROXYTRYPTAMINE LEVEL IN MAN
1960
Crystal Engineering through Halogen Bonding: Complexes of Nitrogen Heterocycles with Organic Iodides
2001
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
2012 Standout
Interaction of the effects of tyramine, amphetamine and reserpine in man
1962 StandoutNobel
Cloning and Characterization of a Mammalian Prenyl Protein-specific Protease
1999
POST-HOSPITAL ADJUSTMENT OF CHRONIC MENTAL PATIENTS
1958
Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor.
2001
Works of Robert Patton being referenced
Novel Tricyclic Inhibitors of Farnesyl Protein Transferase
1995
THE PADDINGTON ALCOHOL TEST: A SHORT REPORT
2004
Cost-effectiveness of screening and referral to an alcohol health worker in alcohol misusing patients attending an accident and emergency department: A decision-making approach
2005
The half-life of the ‘teachable moment’ for alcohol misusing patients in the emergency department
2004
Alcohol: a missed opportunity. A survey of all accident and emergency departments in England
2007
Screening and referral for brief intervention of alcohol-misusing patients in an emergency department: a pragmatic randomised controlled trial
2004
Analogues of 1-(3,10-Dibromo-8-chloro-6,11-dihydro-5 H -benzo[5,6]-cyclohepta[1,2- b ]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase
1999
Attitudes towards alcohol of emergency department doctors trained in the detection of alcohol misuse
2004
Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in Vitro Substrates for Farnesyl Protein Transferase and Geranylgeranyl Protein Transferase Type I
1997
Using Perceived Exertion to Prescribe and Monitor Exercise Training Heart Rate
1987
The effects of near maximum exercise on serum enzymes: the exercise profile versus the cardiac profile
1977
Exploring the Role of Bromine at C(10) of (+)-4-[2-[4-(8-Chloro-3,10-dibromo- 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(R)-yl)-1-piperidinyl]-2- oxoethyl]-1-piperidinecarboxamide (Sch-66336): The Discovery of Indolocycloheptapyridine Inhibitors of Farnesyl Protein Transferase
2002
Quinoxaline Studies. III. The Preparation and Physical Properties of Some 2,3-Dialkoxyquinoxalines
1951
On the Use of Sampling in the Field of Public Health
1954
The heart rate, perceived exertion, and pace of the 1.5 mile run
1981
ANALYSIS OF 1955-1956 POPULATION FALL IN NEW YORK STATE MENTAL HOSPITALS IN FIRST YEAR OF LARGE-SCALE USE OF TRANQUILIZING DRUGS
1957
Sch 207278: a novel farnesyl protein transferase inhibitor from an unidentified fungus
1997